Skip to content
Studies have shown that active fund managers routinely underperform the S&P500 index*
Home
Articles
WALL STREET X
Forecasts
Portfolios
Wall Street X
Articles
Forecasts
Portfolios
Search
Results for
{phrase}
(
{results_count}
of
{results_count_total}
)
Displaying
{results_count}
results of
{results_count_total}
Corcept Therapeutics Incorporated (NASDAQ: CORT)
CORT Stock Predictions and Ratings
WSX Rating:
STRONG BUY
WSX Forecast (1yr):
165.70%
Analyst Rating:
STRONG BUY
Analyst Forecast (1yr):
25.60%
CORT Stock Analysis
CORT
PE Ratio:
207.6
CORT
PEG Ratio:
0.8
CORT
Forward EPS Growth (12 month):
264.30%
CORT
PS Ratio:
10.1
CORT
PSG Ratio:
0.3
CORT
Forward Revenue Growth (12 month):
31.20%
CORT Articles
No data was found